Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Precision Diagnosis and Treatment for Advanced Non-Small-Cell Lung Cancer.

× No keyword cloud information.

218 in total

1. Clinical Validation of Discordant Trunk Driver Mutations in Paired Primary and Metastatic Lung Cancer Specimens.

Authors: Li-Hui Tseng; Federico De Marchi; Aparna Pallavajjalla; Erika Rodriguez; Rena Xian; Deborah Belchis; Christopher D Gocke; James R Eshleman; Peter Illei; Ming-Tseh Lin
Journal: Am J Clin Pathol Date: 2019-10-07 Impact factor: 2.493

2. No room for statins in the quest for survival benefits in small cell lung cancer.

Authors: Francesco Facchinetti; Marcello Tiseo
Journal: Transl Lung Cancer Res Date: 2018-04

3. Rapid expansion in the WAVE bioreactor of clinical scale cells for tumor immunotherapy.

Authors: Yiming Meng; Jing Sun; Tingting Hu; Yushu Ma; Tiaozhao Du; Cuicui Kong; Guirong Zhang; Tao Yu; Haozhe Piao
Journal: Hum Vaccin Immunother Date: 2018-06-28 Impact factor: 3.452

Review 4. The biology and management of non-small cell lung cancer.

Authors: Roy S Herbst; Daniel Morgensztern; Chris Boshoff
Journal: Nature Date: 2018-01-24 Impact factor: 49.962

5. The Atypical Receptor CCRL2 Is Essential for Lung Cancer Immune Surveillance.

Authors: Annalisa Del Prete; Francesca Sozio; Tiziana Schioppa; Andrea Ponzetta; William Vermi; Stefano Calza; Mattia Bugatti; Valentina Salvi; Giovanni Bernardini; Federica Benvenuti; Annunciata Vecchi; Barbara Bottazzi; Alberto Mantovani; Silvano Sozzani
Journal: Cancer Immunol Res Date: 2019-09-04 Impact factor: 11.151

6. Driving the discussion about the greater propensity for doing better with neoadjuvant chemotherapy for non-small cell lung cancer.

Authors: Abigail K Zamora; Anthony W Kim
Journal: J Thorac Dis Date: 2019-10 Impact factor: 2.895

7. [Local consolidative therapy vs. maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer: long-term results of a multi-institutional, phase II, randomized study].

Authors: Alexander Fabian; Florian Pyschny; David Krug
Journal: Strahlenther Onkol Date: 2019-12 Impact factor: 3.621

Review 8. Anlotinib as a molecular targeted therapy for tumors.

Authors: Yi Gao; Pengfei Liu; Ruihua Shi
Journal: Oncol Lett Date: 2020-05-28 Impact factor: 2.967

9. Wide Expression and Significance of Alternative Immune Checkpoint Molecules, B7x and HHLA2, in PD-L1-Negative Human Lung Cancers.

Authors: Haiying Cheng; Alain Borczuk; Murali Janakiram; Xiaoxin Ren; Juan Lin; Amer Assal; Balazs Halmos; Roman Perez-Soler; Xingxing Zang
Journal: Clin Cancer Res Date: 2018-01-26 Impact factor: 12.531

Review 10. [Role of visceral surgery in oligometastases of non-gastrointestinal tumors].

Authors: R Wahba; D Stippel; C Bruns
Journal: Chirurg Date: 2018-07 Impact factor: 0.955